286 related articles for article (PubMed ID: 24416132)
21. MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours.
Green AR; Aleskandarany MA; Agarwal D; Elsheikh S; Nolan CC; Diez-Rodriguez M; Macmillan RD; Ball GR; Caldas C; Madhusudan S; Ellis IO; Rakha EA
Br J Cancer; 2016 Apr; 114(8):917-28. PubMed ID: 26954716
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.
Kim JY; Lee E; Park K; Park WY; Jung HH; Ahn JS; Im YH; Park YH
Oncotarget; 2017 Apr; 8(17):27997-28007. PubMed ID: 28427202
[TBL] [Abstract][Full Text] [Related]
23. Genome profiling of ERBB2-amplified breast cancers.
Sircoulomb F; Bekhouche I; Finetti P; Adélaïde J; Ben Hamida A; Bonansea J; Raynaud S; Innocenti C; Charafe-Jauffret E; Tarpin C; Ben Ayed F; Viens P; Jacquemier J; Bertucci F; Birnbaum D; Chaffanet M
BMC Cancer; 2010 Oct; 10():539. PubMed ID: 20932292
[TBL] [Abstract][Full Text] [Related]
24. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
[TBL] [Abstract][Full Text] [Related]
25. Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Park C; Yoon KA; Kim J; Park IH; Park SJ; Kim MK; Jang W; Cho SY; Park B; Kong SY; Lee ES
Cancer Sci; 2019 May; 110(5):1760-1770. PubMed ID: 30811755
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers.
Arora A; Parvathaneni S; Aleskandarany MA; Agarwal D; Ali R; Abdel-Fatah T; Green AR; Ball GR; Rakha EA; Ellis IO; Sharma S; Madhusudan S
Mol Cancer Ther; 2017 Jan; 16(1):239-250. PubMed ID: 27837030
[TBL] [Abstract][Full Text] [Related]
27. Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients.
Li Z; Guo X; Wu Y; Li S; Yan J; Peng L; Xiao Z; Wang S; Deng Z; Dai L; Yi W; Xia K; Tang L; Wang J
Breast Cancer Res Treat; 2015 Feb; 149(3):767-79. PubMed ID: 25636590
[TBL] [Abstract][Full Text] [Related]
28. DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
Flanagan JM; Cocciardi S; Waddell N; Johnstone CN; Marsh A; Henderson S; Simpson P; da Silva L; ; Khanna K; Lakhani S; Boshoff C; Chenevix-Trench G
Am J Hum Genet; 2010 Mar; 86(3):420-33. PubMed ID: 20206335
[TBL] [Abstract][Full Text] [Related]
29. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
30. Identification of 5 novel genes methylated in breast and other epithelial cancers.
Hill VK; Hesson LB; Dansranjavin T; Dallol A; Bieche I; Vacher S; Tommasi S; Dobbins T; Gentle D; Euhus D; Lewis C; Dammann R; Ward RL; Minna J; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Mar; 9():51. PubMed ID: 20205715
[TBL] [Abstract][Full Text] [Related]
31. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
[TBL] [Abstract][Full Text] [Related]
32. Tissue specific DNA methylation in normal human breast epithelium and in breast cancer.
Avraham A; Cho SS; Uhlmann R; Polak ML; Sandbank J; Karni T; Pappo I; Halperin R; Vaknin Z; Sella A; Sukumar S; Evron E
PLoS One; 2014; 9(3):e91805. PubMed ID: 24651077
[TBL] [Abstract][Full Text] [Related]
33. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.
Kresse SH; Skårn M; Ohnstad HO; Namløs HM; Bjerkehagen B; Myklebost O; Meza-Zepeda LA
Mol Cancer; 2008 Jun; 7():48. PubMed ID: 18522746
[TBL] [Abstract][Full Text] [Related]
34. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
35. Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors.
Jahangiri R; Mosaffa F; Emami Razavi A; Teimoori-Toolabi L; Jamialahmadi K
J Cell Physiol; 2018 Sep; 233(9):7305-7319. PubMed ID: 29574992
[TBL] [Abstract][Full Text] [Related]
36. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
[TBL] [Abstract][Full Text] [Related]
37. Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.
Perez-Janices N; Blanco-Luquin I; Torrea N; Liechtenstein T; Escors D; Cordoba A; Vicente-Garcia F; Jauregui I; De La Cruz S; Illarramendi JJ; Coca V; Berdasco M; Kochan G; Ibañez B; Lera JM; Guerrero-Setas D
Oncotarget; 2015 Sep; 6(27):23944-58. PubMed ID: 26284587
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
Natrajan R; Wilkerson PM; Marchiò C; Piscuoglio S; Ng CK; Wai P; Lambros MB; Samartzis EP; Dedes KJ; Frankum J; Bajrami I; Kopec A; Mackay A; A'hern R; Fenwick K; Kozarewa I; Hakas J; Mitsopoulos C; Hardisson D; Lord CJ; Kumar-Sinha C; Ashworth A; Weigelt B; Sapino A; Chinnaiyan AM; Maher CA; Reis-Filho JS
J Pathol; 2014 Apr; 232(5):553-65. PubMed ID: 24395524
[TBL] [Abstract][Full Text] [Related]
39. Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9.
Vincent-Chong VK; Anwar A; Karen-Ng LP; Cheong SC; Yang YH; Pradeep PJ; Rahman ZA; Ismail SM; Zaini ZM; Prepageran N; Kallarakkal TG; Ramanathan A; Mohayadi NA; Rosli NS; Mustafa WM; Abraham MT; Tay KK; Zain RB
PLoS One; 2013; 8(2):e54705. PubMed ID: 23405089
[TBL] [Abstract][Full Text] [Related]
40. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype.
Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M
Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
